Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
Extended treatment protocol for subjects continuing to benefit from ibrutinib after completion of ibrutinib clinical trials
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.